KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Takeda Pharmaceutical (TAK) Short-term Investments (2018 - 2026)

Takeda Pharmaceutical has reported Short-term Investments over the past 9 years, most recently at $2.8 billion for Q1 2026.

  • For Q1 2026, Short-term Investments rose 21.89% year-over-year to $2.8 billion; the TTM value through Mar 2026 reached $2.8 billion, up 21.89%, while the annual FY2026 figure was $2.9 billion, 26.79% up from the prior year.
  • Short-term Investments was $2.8 billion for Q1 2026 at Takeda Pharmaceutical, up from $2.3 billion in the prior quarter.
  • Across five years, Short-term Investments topped out at $2.8 billion in Q1 2026 and bottomed at $101.8 million in Q1 2024.
  • The 5-year median for Short-term Investments is $217.7 million (2022), against an average of $1.1 billion.
  • Year-over-year, Short-term Investments tumbled 37.02% in 2022 and then skyrocketed 2160.39% in 2025.
  • Over 5 years, Short-term Investments stood at $217.7 million in 2022, then fell by 29.96% to $152.5 million in 2023, then tumbled by 33.24% to $101.8 million in 2024, then skyrocketed by 2160.39% to $2.3 billion in 2025, then rose by 21.89% to $2.8 billion in 2026.
  • The last three reported values for Short-term Investments were $2.8 billion (Q1 2026), $2.3 billion (Q1 2025), and $101.8 million (Q1 2024) per Business Quant data.